Prolonged thromboprophylaxis following hip replacement surgery--results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)

Dahl, O E; Andreassen, G; Aspelin, T; Müller, C; Mathiesen, P; Nyhus, S; Abdelnoor, M; Solhaug, J H; Arnesen, H

Dahl, O E; Andreassen, G; Aspelin, T; Müller, C; Mathiesen, P; Nyhus, S; Abdelnoor, M; Solhaug, J H; Arnesen, H.

Affiliation

Dahl OE; Department of Orthopaedics, Ullevaal University Hospital, Oslo, Norway. odahl@ulril.uio.no

Thromb Haemost ; 77(1): 26-31, 1997 Jan.

Article in En | MEDLINE | ID: mdl-9031444

Subject(s)

Anticoagulants/administration & dosage; Dalteparin/administration & dosage; Hip Prosthesis/adverse effects; Hip/surgery; Postoperative Complications/prevention & control; Thrombosis/prevention & control; Adult; Aged; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Thrombosis/etiology; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Postoperative Complications / Thrombosis / Dalteparin / Hip / Hip Prosthesis / Anticoagulants Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Thromb Haemost Year: 1997 Document type: Article

Search on Google

XML

PubMed Links